As of Nov 19, 2026, 1 of 2 active firms rate ESQ a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ESQ EPS & revenue forecast
EPS · NEXT QUARTER
$2.14
Range $2.06 – $2.24 · 3 analysts · +53% YoY
Next period, 3 analysts expect Esquire Financial Holdings Inc to earn $2.14 a share (range $2.06 – $2.24), versus $1.40 a year earlier. Full-year consensus is $7.51, growing to $9.04 the year after.
REVENUE · NEXT QUARTER
$64.6M
Range $63.7M – $66.0M · 3 analysts · +27% YoY
Revenue is expected to reach $64.6M (range $63.7M – $66.0M), +27.0% year-over-year. Full-year consensus is $187.4M, rising to $275.3M next year.
Top analysts covering Esquire Financial Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ESQ.
#1
Timothy Switzer
Keefe, Bruyette & Woods · Rank #9
Neutral
$120.00-7.5% to target
Overall win rate
59%
+ Follow
#2
Steve Moss
Raymond James · Rank #119
Buy
$125.00-3.7% to target
Overall win rate
48%
+ Follow
#3
JC
Justin Crowley
Piper Sandler
Buy
$125.00-3.7% to target
Coverage
—
+ Follow
#4
TS
Tim Switzer
Keefe, Bruyette & Woods
Neutral
$125.00-3.7% to target
Coverage
—
+ Follow
ESQ stock forecast FAQ
What is ESQ's average 12-month price target?+
The 2 active firms with a live target average $122.50 for Esquire Financial Holdings Inc over the next 12 months, ranging from a $125.00 high to a $120.00 low, as of Nov 19, 2026.
Is ESQ stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ESQ?+
The Street-high target is $125.00 (Raymond James), and the Street-low is $120.00 (Keefe, Bruyette & Woods). The average of all 2 active-firm targets is $122.50.
How many active Wall Street firms cover ESQ?+
2 active firms have a recognized rating on Esquire Financial Holdings Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ESQ?+
Among analysts who currently cover ESQ, Timothy Switzer of Keefe, Bruyette & Woods has the strongest overall Quantellect track record (Rank #9). Their current call is Neutral with a $120.00 target.
What is Esquire Financial Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $2.14 per share (range $2.06 – $2.24) across 3 analysts. Full-year EPS is projected at $7.51, rising to $9.04 the following year.
How much revenue is Esquire Financial Holdings Inc expected to report next quarter?+
Consensus revenue is $64.6M (range $63.7M – $66.0M). Full-year revenue is projected at $187.4M, growing to $275.3M next year.
Have analysts been upgrading or downgrading ESQ lately?+
As of Nov 19, 2026, 1 of 2 active firms rate ESQ a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ESQ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.